Experiments on mice and human cells reveal that the number of specialised immune cells ready to combat skin cancer increased when a novel therapy prevented their egress from melanoma tumours.
he UCL Cancer Center researchers have offered essential molecular insights of how injury may lead to the formation of glioma, a relatively rare but typically aggressive kind of brain tumour.
A study found that patients with brain or spine cancer who are unemployed may experience more intense pain, discomfort, concern, and depressive symptoms than those with the same conditions who are employed.
Cedars-Sinai Cancer Center researchers confirmed in a large-scale nationwide survey that pancreatic cancer rates are growing and rising faster among younger women, than males of the same age. Their findings were published in the peer-reviewed journal Gastroenterology.
Some cancers respond well to immunotherapy, a medication therapy that prompts the immune system to target tumours, although results against lung cancer have been conflicting.
The presence of a brain tumour can be determined by identifying a crucial membrane protein in urine, according to research from Nagoya University in Japan. By eliminating the need for intrusive tests and raising the possibility that tumours are found early enough for surgery, their protein m
A mechanism has been identified by researchers from the University of Michigan Rogel Cancer Center that explains why some patients' cancers grow in response to immunotherapy rather than shrinking.
A new atlas maps more than 300 protein kinases found in human cells and identifies which types of protein substrates they target. The atlas could help scientists understand what happens when cells become cancerous or are treated with specific drugs.
Researchers have uncovered a series of molecular interactions that may be crucial in preventing the spread of cancer cells. There is currently no effective therapeutic strategy to stop metastasis, which is the main cause of death from solid malignant tumours.
Hepatocellular carcinoma (HCC), the most common type of liver cancer, is already the third leading cause of cancer-related deaths worldwide--and cases are on the rise in both the United States and around the world. While chemotherapy, surgery, and liver transplants can benefit some patients,